NDC 70518-4435
Levothyroxine Sodium 75 ug tablet
On the label: Remedyrepack Inc.. It's repackaged: Remedyrepack Inc. rebottles it from Macleods Pharmaceuticals Limited's NDC 33342-395.
Where the pills inside were made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Macleods Pharmaceuticals Limited | Valsad, India | Makes it, makes the active ingredient, tests it, packages it, labels it and mills it | Problems found, fixed voluntarilyAug 4, 2026 · 5 inspections |
Recalls
- Feb 26, 2026 · Class II · Macleods Pharma Usa, Inc
Subpotent Drug
Lots: Lot 16240062A, exp date 3/2026 - May 29, 2025 · Class III · Macleods Pharmaceuticals Ltd
Presence of a foreign substance: black hair found embedded in tablet.
Lots: Lot #: MLF2401A, Exp 01/31/2026
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Levothyroxine: every company that makes it
- Form
- tablet, oral
- Strength
- 75 ug
- Approval
- ANDA ANDA211417
- On the market since
- Aug 12, 2025
- Package NDCs
70518-4435-0- Official label
- DailyMed (National Library of Medicine), updated Sep 11, 2026
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?